About
We aim to develop innovative and personalized antimicrobial pharmacological approaches in order to reduce infectious disease related morbidity and mortality.
Aims
- We aim to study drug behavior with the goal to improve the treatment of bacterial infections
- We aim to explore the contribution of renal function on the exposure of antimicrobial agents
- We aim to investigate drug-drug interactions of antimicrobial agents
- We aim to quantify the relation between drug exposure and emergence of resistance
- We aim to prevent further emergence of resistance of bacterial pathogens to antimicrobial agents
- We aim to implement model informed precision dosing in clinical practice and study its potential
- We aim to set up and maintain international networks to perform these studies
- We aim to contribute to treatment guidelines of bacterial infections
- We aim to bring findings from research to the bedside by means of specialty consulting
- We aim to improve knowledge on pharmacokinetics and pharmacodynamics by organizing targeted courses
Internationally we are also known as
Center of Expertise in Mycology
Research programs
Programs that are connected to this research group.